Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Chi Leung Chiang"'
Publikováno v:
Hong Kong Journal of Radiology. 23:185-190
Autor:
Feng-Ming Spring Kong, Ka-On Lam, Jian Yue Jin, Tai-Chung Lam, Ian C. K. Wong, Horace C.W. Choi, Tsz Him So, Wing-Lok Chan, Victor C. S. Lee, Chi-Leung Chiang, Sik Kwan Chan, Dora L.W. Kwong, Simon Law
Publikováno v:
Advances in Radiation Oncology
Advances in Radiation Oncology, Vol 5, Iss 5, Pp 880-888 (2020)
Advances in Radiation Oncology, Vol 5, Iss 5, Pp 880-888 (2020)
Purpose: We hypothesized that radiation-induced lymphopenia could be predicted by the effective dose to the circulating immune cells (EDIC) in advanced esophageal squamous cell carcinoma treated with trimodality therapy according to the Dutch ChemoRa
Autor:
Tianzhu Lu, Eric Sze Chun Chau, Anne Wing Mui Lee, Jianji Pan, Wenqi Chen, Qiaojuan Guo, Peter Ho Yin Luk, Youping Xiao, Shao Hui Huang, Shaojun Lin, Brian O'Sullivan, Chi-Leung Chiang, Wai Tong Ng, Zhiyuan Xu, Jishi Li, Tiffany Sze Wai Ma, Horace Cheuk Wai Choi
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
This study aims to identify prognostic factors in nasopharyngeal carcinoma (NPC) to improve the current 8th edition TNM classification. A systematic review of the literature reported between 2013 and 2019 in PubMed, Embase, and Scopus was conducted.
Autor:
Kwok-Hung Au, Macy Tong, Yuk Tung, Cheuk-Wai Horace Choi, Wai Tong Ng, Kai-Cheong Roger Ngan, Chung-Hang James Chow, Chun-Yin Edwin Wong, Ka-On Lam, Ka-Wai Alice Cheung, Wing-Mui Anne Lee, Pui-Lam Yip, Chi-Leung Chiang, Shing-Fung Lee, K.M. Cheung, Ho-Fun Lee, Ming-Chun Darren Poon, Wing-Yu Jessica Lai, Po-Chung Sunny Chan
Publikováno v:
Cancers, Vol 13, Iss 4286, p 4286 (2021)
Cancers
Volume 13
Issue 17
Cancers
Volume 13
Issue 17
A nomogram was recently published by Sun et al. to predict overall survival (OS) and the additional benefit of concurrent chemoradiation (CCRT) vs. radiotherapy (RT) alone, in stage II NPC treated with conventional RT. We aimed to assess the predicto
Autor:
Shing Fung Lee, Horace C. W. Choi, Sik Kwan Chan, Ka On Lam, Victor H. F. Lee, Irene O. L. Wong, Chi Leung Chiang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
ObjectivesWe aimed to compare the economic value of chemotherapy plus anti-epidermal growth factor receptor (anti-EGFR) monoclonal antibody (mAb) against chemotherapy with bevacizumab (Bev, an anti-vascular endothelial growth factor mAb) as first-lin
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:e35-e36
PURPOSE/OBJECTIVE(S) We reported the first study of combined stereotactic body radiotherapy and immunotherapy (SBRT-IO) in unresectable hepatocellular carcinoma (uHCC) and found this combination was synergistic and safe. Based on these results, we co
Publikováno v:
Cancers
Volume 13
Issue 5
Cancers, Vol 13, Iss 931, p 931 (2021)
Volume 13
Issue 5
Cancers, Vol 13, Iss 931, p 931 (2021)
Simple Summary There is a growing body of literature demonstrating high cancer drug costs relative to the benefits provided to patients treated on a large scale. We examined the cost-effectiveness of atezolizumab–bevacizumab for the first-line trea
Autor:
S Y Yeung, Ka-On Lam, K S Lau, H C Choi, S F Lee, K K Yuen, Siok-Yee Chan, Chi-Leung Chiang, B Y Chan, TS Choy
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 15:5-13
AIM To investigate treatment patterns and outcomes of metastatic colorectal cancer (mCRC) patients beyond second progression (PD2) since regorafenib and TAS-102 became available in Hong Kong. METHODS The clinical records of consecutive mCRC patients
Autor:
Connie H. M. Ho, Frank Cs. Wong, Kelvin K. K. Ng, Victor Lee, Siu-Ho Chok, W.C. Dai, Cynthia S Y Yeung, Chi-Leung Chiang, To-Wai Leung, Albert Cy Chan, Tan To Cheung, T Wong, Mai-Yee Luk, Chung Mau Lo, Ann-Shing Lee
Publikováno v:
Surgical Oncology. 28:228-235
Background This study compared outcomes of nonresectable hepatocellular carcinoma (HCC) who had transarterial chemoembolization (TACE) vs. stereotactic body radiation therapy (SBRT) after TACE (TACE + SBRT). Methods This was a retrospective study of
Autor:
Venus W Y Lee, Cynthia S Y Yeung, Kam Sze Tsang, Natalie S. M. Wong, Connie H. M. Ho, S. K. Ha, Mark ka heng Chan, Francis A. S. Lee, Chi-Leung Chiang, B. Wang
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
Scientific Reports
Scientific Reports
This study aims at evaluating the symptom response, response duration, and toxicity of single dose palliative liver radiotherapy (RT) for symptomatic HCC patients. We reviewed unresectable HCC patients treated with palliative RT in our institution. E